New cementitious materials based on alkali-activated fly ash: performance at high temperatures

This paper reports on a comparative study of the mechanical performance at different temperatures of a commercial Portland cement, used as a control, and a new cementitious material made from an 8M-NaOH activated fly ash and containing no OPC. Two types of mechanical tests were conducted: (i) high temperature mechanical tests, to determine the strength and fracture toughness of the two materials between 251 and 6001C, and (ii) post-thermal treatment tests, to evaluate the residual strength after 1 h of exposure to different temperatures (2001, 4001, 6001, 8001, and 10001C). In both cases, the results showed that the new cementitious material performed significantly better at high temperatures than the Portland cement control. Differential thermogravimetry (DTG)/TG, Fourier transform infrared (FTIR), and X-ray diffraction analyses were also conducted to analyze the mineralogical and microstructural variations taking place in the material as a result of high temperature exposure. The results of these tests were correlated with the mechanical behaviour observed

Comportamiento mecánico a altas temperaturas de cementos de ceniza volante activados alcalinamente

En este trabajo se realiza un estudio comparativo del comportamiento mecánico, en función de la temperatura, entre un cemento Portland comercial, utilizado de referencia y dos nuevos materiales cementantes. Los ensayos realizados se han centrado en muestras de cemento portland , muestras de cenizas volantes activadas con un 100% de silicato sódico y muestras con un 70% de ceniza y un 30% de cemento activadas con un activador en estado sólido.Se realizaron dos tipos de ensayos: 1) post tratamiento térmico, donde se evaluó la resistencia mecánica residual tras una hora de exposición térmica a diferentes temperaturas, y 2) ensayos mecánicos a altas temperaturas , donde se determino el comportamiento mecánico y la tenacidad a la fractura a distintas temperaturas. Técnicas de Rayos X y microscopía electrónica de barrido han sido utilizadas para analizar las variaciones microestructurales en los materiales, como consecuencia de la exposición a altas temperaturas

Mechanical behavior of alkali-cement as function of the temperature.

This investigation reports on a comparative study of the mechanical behavior at different temperatures of three different alkali-activated fly ash pastes chemically activated using sodium silicate. A control Portland cement (OPC) was used as a reference. In an attempt to simulate the conditions prevailing in the event of accidental fire, post-thermal mechanical tests were performed to determine the residual strength. It has therefore been established that FA based cements can be fabricated for construction purposes and these materials have great potential for fire resistance applications

Simulation of Rapidly-Exploring Random Trees in Membrane Computing with P-Lingua and Automatic Programming

Methods based on Rapidly-exploring Random Trees (RRTs) have been widely used in robotics to solve motion planning problems. On the other hand, in the membrane computing framework, models based on Enzymatic Numerical P systems (ENPS) have been applied to robot controllers, but today there is a lack of planning algorithms based on membrane computing for robotics. With this motivation, we provide a variant of ENPS called Random Enzymatic Numerical P systems with Proteins and Shared Memory (RENPSM) addressed to implement RRT algorithms and we illustrate it by simulating the bidirectional RRT algorithm. This paper is an extension of [21]a. The software presented in [21] was an ad-hoc simulator, i.e, a tool for simulating computations of one and only one model that has been hard-coded. The main contribution of this paper with respect to [21] is the introduction of a novel solution for membrane computing simulators based on automatic programming. First, we have extended the P-Lingua syntax –a language to define membrane computing models– to write RENPSM models. Second, we have implemented a new parser based on Flex and Bison to read RENPSM models and produce source code in C language for multicore processors with OpenMP. Finally, additional experiments are presented

Caracterización fitoquímica y capacidad antioxidante de especies de Briofitas colectadas en el NOA

Las briofitas conforman un amplio grupo integrado por unas 22.000 especies deplantas pequeñas que crecen habitualmente en zonas húmedas sobre el suelo,troncos de árboles y rocas, son plantas embrionarias no vasculares que incluyenmusgos, hepáticas y antocerotes.No se han realizado muchos estudios de fitoquímica y bioactividades en briofitas, esto se debe a que son morfológicamente muy pequeñas y difíciles de recoger en grandes cantidades como muestra pura. Sin embargo, algunas de ellas han tenido tradicionalmente un uso medicinal.El objetivo de este trabajo es realizar una caracterización fitoquímica de extractos de 9 especies de briofitas colectadas en el Noroeste Argentino.Se prepararon extractos acuosos y etanólicos de las 9 especies a estudiar: Plagiochasma intermedium; Pleurochaete luteola; Marchantia papillata; Marchantiaplicata; Targionia hypophylla; Saitobryum lorentzii; Marchantia chenopoda; Anoectangium aestivum; Anoectangium euchloron. A estos extractos se les determinó el contenido de compuestos fenólicos utilizando el método colorimétrico de FolinCiocalteau, el contenido de flavonoides totales usando AlCl₃, y la capacidad antioxidante de los compuestos con el ensayo del radical catiónico ABTS.Los extractos etanólicos de Pleurochaete luteola, Marchantia papillata, Anoectangium aestivum y Anoectangium euchloron presentaron significativamente más compuestos fenólicos; además, Anoectangium aestivum, Anoectangium euchloron contenían más flavonoides que el resto de las especias estudiadas. Pleurochaete luteola y Anoectangium euchloron mostraron mayor capacidad antioxidante. En los extractos acuosos Plagiochasma intermedium y Marchantia papillata presentaron mayor contenido de compuestos fenólicos, pero en concentraciones menores a las de las muestras etanólicas. Anoectangium aestivum y Anoectangium euchloron tuvieron mayor contenido de flavonoides totales. Los extractos acuosos de Plagiochasma intermedium y Pleurochaete luteola resultaron muy buenos antioxidantes con potencia superior a los extractos etanólicos.Los resultados de este trabajo permitieron definir por primera vez que estas especies de briofitas contienen polifenoles y son potencialmente útiles como antioxidantes naturales.Fil: Jimenez, Ignacio. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - Tucumán. Unidad Ejecutora Lillo; Argentina. Universidad Nacional de Tucumán. Instituto de Bioprospección y Fisiología Vegetal. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Bioprospección y Fisiología Vegetal; ArgentinaFil: Alvarez, M.. Universidad Nacional de Tucumán. Instituto de Bioprospección y Fisiología Vegetal. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Bioprospección y Fisiología Vegetal; Argentina. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; ArgentinaFil: Suarez, Guillermo Martin. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico - Tucumán. Unidad Ejecutora Lillo; Argentina. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; ArgentinaFil: Zampini, Iris Catiana. Universidad Nacional de Tucumán. Instituto de Bioprospección y Fisiología Vegetal. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Bioprospección y Fisiología Vegetal; Argentina. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; ArgentinaFil: Isla, Maria Ines. Universidad Nacional de Tucumán. Instituto de Bioprospección y Fisiología Vegetal. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet Noa Sur. Instituto de Bioprospección y Fisiología Vegetal; Argentina. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo; ArgentinaXIV Jornadas Internas de Comunicaciones en Investigación, Docencia y Extensión de la Facultad de Ciencias Naturales e IML, Universidad Nacional de TucumánSan Miguel de TucumánArgentinaUniversidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lill

Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response

Breast cancer; Liquid biopsy; Neoadjuvant therapyCàncer de mama; Biòpsia líquida; Teràpia neoadjuvantCáncer de mama; Biopsia líquida; Terapia neoadyuvanteBackground: Although the standard of care is to perform surgery of primary breast cancer (BC) after neoadjuvant chemotherapy (NAC), for certain patients achieving clinical complete response (cCR) and pathologic complete response (pCR), omission of surgical treatment may be an option. Levels of circulating tumor DNA (ctDNA) during and after therapy could identify patients achieving minimal residual disease. In this study, we evaluated whether ctDNA clearance during NAC could be a correlate to effective response in human epidermal growth factor receptor 2 positive (HER2+) and triple-negative (TN) BC patients. Methods: A prospective study was conducted to identify patient-specific PIK3CA and TP53 mutations in tissue using next-generation sequencing, which could then be used to track the presence/absence of mutations prior to, during, and following NAC using Sysmex SafeSEQ technology. All patients underwent a surgical excision after NAC, and pCR was assessed. Results: A total of 29 TN and HER2+ BC patients were examined and 20 that carried mutations in the PIK3CA and/or TP53 genes were recruited. Overall, 19 of these 20 patients harbored at least one tumor-specific mutation in their plasma at baseline. After NAC, 15 patients (75.0%) achieved pCR according to the histopathologic evaluation of the surgical specimen, and 15 patients (75.0%) had a cCR; 18 of 20 patients (90.0%) had concordant pCR and cCR. The status of ‘no mutation detected’ (NMD) following NAC in cCR patients correctly identified the pCR in 14 of 15 patients (93.33%), as well as correctly ruled out pCR in three patients, with an accuracy of 89.47%. During the 12-month follow-up after surgery, 40 plasma samples collected from 15 patients all showed no detectable ctDNA (NMD), and no patient recurred. Conclusion: These findings prompt further research of the value of ctDNA for non-invasive prediction of clinical/pathological response, raising the possibility of sparing surgery following NAC in selected BC patients.The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by a grant from Sysmex Inostics, Inc. The sponsor coordinated data collection from study centers, and funded the statistical analysis and medical writing assistance

Reconstitution of the Ataxia-Telangiectasia Cellular Phenotype With Lentiviral Vectors

Ataxia-telangiectasia (A-T) is a complex disease arising from mutations in the ATM gene (Ataxia-Telangiectasia Mutated), which plays crucial roles in repairing double-strand DNA breaks (DSBs). Heterogeneous immunodeficiency, extreme radiosensitivity, frequent appearance of tumors and neurological degeneration are hallmarks of the disease, which carries high morbidity and mortality because only palliative treatments are currently available. Gene therapy was effective in animal models of the disease, but the large size of the ATM cDNA required the use of HSV-1 or HSV/AAV hybrid amplicon vectors, whose characteristics make them unlikely tools for treating A-T patients. Due to recent advances in vector packaging, production and biosafety, we developed a lentiviral vector containing the ATM cDNA and tested whether or not it could rescue cellular defects of A-T human mutant fibroblasts. Although the cargo capacity of lentiviral vectors is an inherent limitation in their use, and despite the large size of the transgene, we successfully transduced around 20% of ATM-mutant cells. ATM expression and phosphorylation assays indicated that the neoprotein was functional in transduced cells, further reinforced by their restored capacity to phosphorylate direct ATM substrates such as p53 and their capability to repair radiation-induced DSBs. In addition, transduced cells also restored cellular radiosensitivity and cell cycle abnormalities. Our results demonstrate that lentiviral vectors can be used to rescue the intrinsic cellular defects of ATM-mutant cells, which represent, in spite of their limitations, a proof-of-concept for A-T gene therapy

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

BACKGROUND: MicroRNAs (miRNAs) have a crucial role in regulating immune response against infectious diseases, showing changes early in disease onset and before the detection of the pathogen. Thus, we aimed to analyze the plasma miRNA profile at COVID-19 onset to identify miRNAs as early prognostic biomarkers of severity and survival. METHODS AND RESULTS: Plasma miRNome of 96 COVID-19 patients that developed asymptomatic/mild, moderate and severe disease was sequenced together with a group of healthy controls. Plasma immune-related biomarkers were also assessed. COVID-19 patients showed 200 significant differentially expressed (SDE) miRNAs concerning healthy controls, with upregulated putative targets of SARS-CoV-2, and inflammatory miRNAs. Among COVID-19 patients, 75 SDE miRNAs were observed in asymptomatic/mild compared to symptomatic patients, which were involved in platelet aggregation and cytokine pathways, among others. Moreover, 137 SDE miRNAs were identified between severe and moderate patients, where miRNAs targeting the SARS CoV-2 genome were the most strongly disrupted. Finally, we constructed a mortality predictive risk score (miRNA-MRS) with ten miRNAs. Patients with higher values had a higher risk of 90-days mortality (hazard ratio = 4.60; p-value < 0.001). Besides, the discriminant power of miRNA-MRS was significantly higher than the observed for age and gender (AUROC = 0.970 vs. 0.881; p = 0.042). CONCLUSIONS: SARS-CoV-2 infection deeply disturbs the plasma miRNome from an early stage of COVID-19, making miRNAs highly valuable as early predictors of severity and mortality

Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of vitamin D on ventricular remodelling in patients with anterior myocardial infarction: the VITamin D in Acute Myocardial Infarction (VITDAMI) trial

Introduction:Decreased plasma vitamin D (VD) levels are linked to cardiovascular damage. However, clinical trials have not demonstrated a benefit of VD supplements on left ventricular (LV) remodelling. Anterior ST-elevation acute myocardial infarction (STEMI) is the best human model to study the effect of treatments on LV remodelling. We present a proof-of-concept study that aims to investigate whether VD improves LV remodelling in patients with anterior STEMI. Methods and analysis:The VITamin D in Acute Myocardial Infarction (VITDAMI) trial is a multicentre, randomised, double-blind, placebo-controlled trial. 144 patients with anterior STEMI will be assigned to receive calcifediol 0.266 mg capsules (Hidroferol SGC)/15 days or placebo on a 2:1 basis during 12 months. Primary objective:to evaluate the effect of calcifediol on LV remodelling defined as an increase in LV end-diastolic volume >= 10\% (MRI). Secondary objectives:change in LV end-diastolic and end-systolic volumes, ejection fraction, LV mass, diastolic function, sphericity index and size of fibrotic area; endothelial function; plasma levels of aminoterminal fragment of B-type natriuretic peptide, galectin-3 and monocyte chemoattractant protein-1; levels of calcidiol (VD metabolite) and other components of mineral metabolism (fibroblast growth factor-23 (FGF-23), the soluble form of its receptor klotho, parathormone and phosphate). Differences in the effect of VD will be investigated according to the plasma levels of FGF-23 and klotho. Treatment safety and tolerability will be assessed. This is the first study to evaluate the effect of VD on cardiac remodelling in patients with STEMI. Ethics and dissemination: This trial has been approved by the corresponding Institutional Review Board (IRB) and National Competent Authority (Agencia Espanola de Medicamentos y Productos Sanitarios (AEMPS)). It will be conducted in accordance with good clinical practice (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use-Good Clinical Practice (ICH-GCP)) requirements, ethical principles of the Declaration of Helsinki and national laws. The results will be submitted to indexed medical journals and national and international meetings.The VITDAMI trial is an investigator initiated study, sponsored by the Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS-FJD). Funding has been obtained from Fondo de Investigaciones Sanitarias (PI14/01567; http://www.isciii.es/) and Spanish Society of Cardiology (http://secardiologia.es/). In addition, the study medication has been provided freely by the pharmaceutical Company FAES FARMA S.A. (Leioa, Vizcaya, Spain; http://faesfarma.com/). This company was the only funder who collaborated in study design (IG-H).S

Estudio de perfiles de difracción de rayos X de una aleación Ti-13Ta-3Sn obtenida por aleado mecánico

Las aleaciones Ti-β se han vuelto altamente demandadas en la industria, por sus buenas características físicas y químicas. En el presente trabajo, se sintetizó una aleación Ti-13Ta-3Sn (%at) por aleado mecánico con tiempos entre 2 y 100h. Las aleaciones se caracterizaron por difracción de rayos X (DRX) y los patrones se analizaron por el método Rietveld con el software MAUD. Se caracterizaron los cambios microestructurales y la evolución de las fases Ti-α y Ti-β. Se identificó la presencia una nueva fase metaestable fcc y la síntesis de una aleación con un 79,80% en peso de fase Ti-β, ambas con tamaño de cristalita nanométrico. Palabras clave: Aleado mecánico, aleación Ti-β, difracción de rayos X